LINEAGE CELL THERAPEUTICS IN (LCTX) Top Institutional Shareholders
LINEAGE CELL THERAPEUTICS IN (LCTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $175.59M in LCTX holdings during the latest filing period.
Broadwood Capital Inc is currently the largest disclosed institutional shareholder of LCTX tracked by InsiderSet, reporting ownership valued at approximately $78.31M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $61.95M, representing an estimated loss of -20.89% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 83% of the total disclosed LCTX value among the investors covered in this analysis. Major shareholders include Broadwood Capital Inc, Vanguard Capital Management Llc, Defender Capital, Llc., and several other long-term asset managers with concentrated positions in LINEAGE CELL THERAPEUTICS IN (LCTX).
This page ranks the largest institutional LCTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
126
Total Reported Value
$175.59M
Largest Holder
Broadwood Capital Inc
Largest Position
$78.31M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
142
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Broadwood Capital Inc | 5.52% | 49,560,992 | $78,306,367 | $61,951,240 | -$16,355,127 | -20.89% | |
| Vanguard Capital Management Llc | 0.00% | 8,318,685 | $13,143,522 | $10,398,356 | -$2,745,166 | -20.89% | |
| Defender Capital, Llc. | 3.77% | 6,729,599 | $10,632,766 | $8,411,999 | -$2,220,767 | -20.89% | |
| Millennium Management Llc | 0.01% | 5,561,374 | $8,786,971 | $6,951,718 | -$1,835,254 | -20.89% | |
| Raffles Associates Lp | 7.35% | 5,362,788 | $8,473,205 | $6,703,485 | -$1,769,720 | -20.89% | |
| Fifth Third Bancorp | 0.01% | 4,600,000 | $7,268,000 | $5,750,000 | -$1,518,000 | -20.89% | |
| Blackrock, Inc. | 0.00% | 3,864,757 | $6,106,316 | $4,830,946 | -$1,275,370 | -20.89% | |
| Armistice Capital, Llc | 0.17% | 3,182,799 | $5,028,822 | $3,978,499 | -$1,050,323 | -20.89% | |
| Marshall Wace, Llp | 0.01% | 3,065,033 | $4,842,750 | $3,831,291 | -$1,011,459 | -20.89% | |
| Geode Capital Management, Llc | 0.00% | 2,523,114 | $3,988,508 | $3,153,893 | -$834,616 | -20.93% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 2,125,100 | $3,357,658 | $2,656,375 | -$701,283 | -20.89% |
| Morgan Stanley | 0.00% | 1,868,491 | $2,952,215 | $2,335,614 | -$616,601 | -20.89% | |
| Ubs Group Ag | 0.00% | 1,370,461 | $2,165,328 | $1,713,076 | -$452,252 | -20.89% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,324,158 | $2,092,170 | $1,655,198 | -$436,973 | -20.89% | |
| Susquehanna International Group, Llp | 0.00% | 1,304,685 | $2,061,403 | $1,630,856 | -$430,547 | -20.89% | |
| Goldman Sachs Group Inc | 0.00% | 1,169,427 | $1,847,695 | $1,461,784 | -$385,911 | -20.89% | |
| State Street Corp | 0.00% | 1,090,111 | $1,722,375 | $1,362,639 | -$359,736 | -20.89% | |
| Jane Street Group, Llc | 0.00% | 993,208 | $1,569,269 | $1,241,510 | -$327,759 | -20.89% | |
| Red Crane Wealth Management, Llc | 0.78% | 597,263 | $943,676 | $746,579 | -$197,097 | -20.89% | |
| Northern Trust Corp | 0.00% | 499,127 | $788,621 | $623,909 | -$164,712 | -20.89% | |
| Sei Investments Co | 0.00% | 422,274 | $667,195 | $527,843 | -$139,353 | -20.89% | |
| Bank Of America Corp | 0.00% | 419,355 | $662,580 | $524,194 | -$138,386 | -20.89% | |
| Barclays Plc | 0.00% | 393,309 | $621,429 | $491,636 | -$129,793 | -20.89% | |
| Informed Momentum Co Llc | 0.06% | 346,615 | $547,652 | $433,269 | -$114,383 | -20.89% | |
| Point72 Asset Management, L.P. | 0.00% | 304,363 | $480,894 | $380,454 | -$100,440 | -20.89% | |
| Qube Research & Technologies Ltd | 0.00% | 259,561 | $410,106 | $324,451 | -$85,655 | -20.89% | |
| Bridgeway Capital Management, Llc | 0.01% | 221,000 | $349,180 | $276,250 | -$72,930 | -20.89% | |
| Mcmillan Office, Inc. | 0.04% | 216,000 | $341,280 | $270,000 | -$71,280 | -20.89% | |
| Fmr Llc | 0.00% | 193,308 | $305,426 | $241,635 | -$63,791 | -20.89% | |
| Brevan Howard Capital Management Lp | 0.00% | 186,794 | $295,135 | $233,493 | -$61,643 | -20.89% | |
| Citigroup Inc | 0.00% | 175,078 | $276,623 | $218,848 | -$57,776 | -20.89% | |
| Catalyst Funds Management Pty Ltd | 0.05% | 170,300 | $269,074 | $212,875 | -$56,199 | -20.89% | |
| Squarepoint Ops Llc | 0.00% | 143,190 | $226,240 | $178,988 | -$47,253 | -20.89% | |
| Citadel Advisors Llc | 0.00% | 130,948 | $206,898 | $163,685 | -$43,213 | -20.89% | |
| Charles Schwab Investment Management Inc | 0.00% | 129,924 | $205,280 | $162,405 | -$42,875 | -20.89% | |
| Jain Global Llc | 0.00% | 122,051 | $192,841 | $152,564 | -$40,277 | -20.89% | |
| Hudson Bay Capital Management Lp | 0.00% | 111,287 | $175,833 | $139,109 | -$36,724 | -20.89% | |
| Omers Administration Corp | 0.00% | 109,000 | $172,220 | $136,250 | -$35,970 | -20.89% | |
| Commonwealth Equity Services, Llc | 0.00% | 102,828 | $162,470 | $128,535 | -$33,935 | -20.89% | |
| Williams Jones Wealth Management, Llc. | 0.00% | 101,300 | $160,054 | $126,625 | -$33,429 | -20.89% | |
| Hightower Advisors, Llc | 0.00% | 99,870 | $157,795 | $124,838 | -$32,958 | -20.89% | |
| Two Sigma Investments, Lp | 0.00% | 88,585 | $139,964 | $110,731 | -$29,233 | -20.89% | |
| Vanguard Global Advisers, Llc | 0.00% | 85,795 | $135,556 | $107,244 | -$28,312 | -20.89% | |
| Voleon Capital Management Lp | 0.00% | 85,739 | $135,468 | $107,174 | -$28,294 | -20.89% | |
| Raymond James Financial Inc | 0.00% | 83,984 | $132,695 | $104,980 | -$27,715 | -20.89% | |
| Trust Co Of Toledo Na | 0.01% | 83,795 | $132,396 | $104,744 | -$27,652 | -20.89% | |
| Summittx Capital, L.P. | 0.00% | 60,833 | $96,116 | $76,041 | -$20,075 | -20.89% | |
| Diametric Capital, Lp | 0.02% | 59,029 | $93,265 | $73,786 | -$19,479 | -20.89% | |
| Schonfeld Strategic Advisors Llc | 0.00% | 48,017 | $75,866 | $60,021 | -$15,845 | -20.89% | |
| Cibc World Market Inc. | 0.00% | 47,050 | $74,339 | $58,813 | -$15,527 | -20.89% |
Frequently asked questions about LCTX
Who owns the most LCTX stock?
The largest holders of LCTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LINEAGE CELL THERAPEUTICS IN (LCTX).
Is LCTX widely held by superinvestors?
Many widely followed stocks like LCTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LCTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.